ARCHIVES

Biotech Firm Plans Custom Clinical trials In USSR for Drug Firms

This article is from The Cancer Letter archive.

Vol. 15 No. 33 | August 18, 1989

Download PDF Visit The Full Archive

Related Articles

In Brief: FDA Advisors Ask Cetus To Refine IL-2 Application; NIH Reauthorization Introduced

August 3, 1990

Breast Cancer Activist, Radiologist Are Added To Special Commission

November 6, 1992

Leter: Payers Must Determine Appropriate Therapies

July 19, 1996

Porter Softens Proposal To require SBIR Scores To Match R01s

July 26, 1996

FDA Updates Safety Labeling Of 5-Alpha Reductase Inhibitors

June 24, 2011

Senate Committee Proposes $100 Million DOD Prostate Cancer Research Program

July 12, 1996